This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Merit Medical Reports Record Revenues For The Quarter And Year Ended December 31, 2012 And Gives Sales And Earnings Guidance For 2013

SOUTH JORDAN, Utah, Feb. 21, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced record revenues of $102.2 million for the quarter ended December 31, 2012, an increase of 12% over revenues of $91.1 million for the quarter ended December 31, 2011. Revenues for the year ended December 31, 2012 were a record $394.3 million, an increase of 10% over revenues of $359.4 million for the year ended December 31, 2011. Revenues from Merit's core business grew 10% and 9% for the quarter and year ended December 31, 2012, respectively, compared to the corresponding periods of 2011. Revenues related to Merit's recent acquisition of Thomas Medical Products Inc. ("Thomas Medical") from a division of GE Healthcare were $1.9 million for the last twelve days of December 2012.

Merit's non-GAAP net income for the quarter ended December 31, 2012 was $6.2 million, or $0.15 per share, compared to $7.4 million, or $0.18 per share, for the quarter ended December 31, 2011. Merit's non-GAAP net income for the year ended December 31, 2012 was $30.8 million, or $0.72 per share, compared to $30.9 million, or $0.78 per share, for the year ended December 31, 2011.

GAAP net income for the quarter ended December 31, 2012 was $641,000, or $0.01 per share, compared to $5.0 million, or $0.12 per share, for the fourth quarter of 2011. GAAP net income for the year ended December 31, 2012 was $19.7 million, or $0.46 per share, compared to $23.0 million, or $0.58 per share, for the year ended December 31, 2011. The decrease in GAAP net income for the quarter and year ended December 31, 2012 was primarily due to $2.2 million, net of tax, for non-recurring costs related to the acquisition of Thomas Medical and $1.5 million for a capital loss related to an investment in a privately-held company.

1 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs